Maxwell Skor
Stock Analyst at Morgan Stanley
(1.00)
# 3,743
Out of 4,944 analysts
5
Total ratings
40%
Success rate
-9.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Maxwell Skor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Overweight | $250 | $196.02 | +27.54% | 1 | Jul 3, 2025 | |
| SANA Sana Biotechnology | Assumes: Overweight | $12 | $3.11 | +285.85% | 1 | Jul 3, 2025 | |
| TCRX TScan Therapeutics | Assumes: Overweight | $10 | $1.67 | +498.80% | 1 | Mar 14, 2025 | |
| IVVD Invivyd | Maintains: Overweight | $9.5 → $3.55 | $0.78 | +354.95% | 2 | Nov 20, 2024 |
Ascendis Pharma
Jul 3, 2025
Assumes: Overweight
Price Target: $250
Current: $196.02
Upside: +27.54%
Sana Biotechnology
Jul 3, 2025
Assumes: Overweight
Price Target: $12
Current: $3.11
Upside: +285.85%
TScan Therapeutics
Mar 14, 2025
Assumes: Overweight
Price Target: $10
Current: $1.67
Upside: +498.80%
Invivyd
Nov 20, 2024
Maintains: Overweight
Price Target: $9.5 → $3.55
Current: $0.78
Upside: +354.95%